174 related articles for article (PubMed ID: 8141578)
1. Improved medium for fluconazole susceptibility testing of Candida albicans.
Rodriguez-Tudela JL; Martinez-Suarez JV
Antimicrob Agents Chemother; 1994 Jan; 38(1):45-8. PubMed ID: 8141578
[TBL] [Abstract][Full Text] [Related]
2. Comparison of a spectrophotometric microdilution method with RPMI-2% glucose with the National Committee for Clinical Laboratory Standards reference macrodilution method M27-P for in vitro susceptibility testing of amphotericin B, flucytosine, and fluconazole against Candida albicans.
Rodríguez-Tudela JL; Berenguer J; Martínez-Suárez JV; Sanchez R
Antimicrob Agents Chemother; 1996 Sep; 40(9):1998-2003. PubMed ID: 8878570
[TBL] [Abstract][Full Text] [Related]
3. Defining conditions for microbroth antifungal susceptibility tests: influence of RPMI and RPMI-2% glucose on the selection of endpoint criteria.
Rodriguez-Tudela JL; Martinez-Suárez JV
J Antimicrob Chemother; 1995 Jun; 35(6):739-49. PubMed ID: 7559186
[TBL] [Abstract][Full Text] [Related]
4. Patterns of in vitro activity of itraconazole and imidazole antifungal agents against Candida albicans with decreased susceptibility to fluconazole from Spain.
Martinez-Suarez JV; Rodriguez-Tudela JL
Antimicrob Agents Chemother; 1995 Jul; 39(7):1512-6. PubMed ID: 7492095
[TBL] [Abstract][Full Text] [Related]
5. Antifungal susceptibility testing of yeasts: evaluation of technical variables for test automation.
Odds FC; Vranckx L; Woestenborghs F
Antimicrob Agents Chemother; 1995 Sep; 39(9):2051-60. PubMed ID: 8540715
[TBL] [Abstract][Full Text] [Related]
6. Comparison of two alternative microdilution procedures with the National Committee for Clinical Laboratory Standards reference macrodilution method M27-P for in vitro testing of fluconazole-resistant and -susceptible isolates of Candida albicans.
Espinel-Ingroff A; Rodríguez-Tudela JL; Martínez-Suárez JV
J Clin Microbiol; 1995 Dec; 33(12):3154-8. PubMed ID: 8586692
[TBL] [Abstract][Full Text] [Related]
7. Collaborative investigation of broth microdilution and semisolid agar dilution for in vitro susceptibility testing of Candida albicans.
Shawar R; Paetznick V; Witte Z; Ensign LG; Anaissie E; LaRocco M
J Clin Microbiol; 1992 Aug; 30(8):1976-81. PubMed ID: 1500502
[TBL] [Abstract][Full Text] [Related]
8. Fluconazole susceptibilities of bloodstream Candida sp. isolates as determined by National Committee for Clinical Laboratory Standards method M27-A and two other methods.
Cantón E; Pemán J; Carrillo-Muñoz A; Orero A; Ubeda P; Viudes A; Gobernado M
J Clin Microbiol; 1999 Jul; 37(7):2197-200. PubMed ID: 10364585
[TBL] [Abstract][Full Text] [Related]
9. Comparison of broth macrodilution, broth microdilution, and E test antifungal susceptibility tests for fluconazole.
Sewell DL; Pfaller MA; Barry AL
J Clin Microbiol; 1994 Sep; 32(9):2099-102. PubMed ID: 7814531
[TBL] [Abstract][Full Text] [Related]
10. Evaluation of the Etest method for determining fluconazole susceptibilities of 402 clinical yeast isolates by using three different agar media.
Pfaller MA; Messer SA; Karlsson A; Bolmström A
J Clin Microbiol; 1998 Sep; 36(9):2586-9. PubMed ID: 9705397
[TBL] [Abstract][Full Text] [Related]
11. Improved method of determining the susceptibility of Candida albicans to fluconazole.
Polanco AM; Rodriguez-Tudela JL; Baquero F; Sanchez-Sousa A; Martinez-Suarez JV
J Antimicrob Chemother; 1995 Jan; 35(1):155-9. PubMed ID: 7768763
[TBL] [Abstract][Full Text] [Related]
12. Antifungal susceptibility testing of Candida albicans by flow cytometry.
Gökahmetoglu S; Nedret Koç A; Patiroglu T
Mycoses; 2003 Sep; 46(8):307-11. PubMed ID: 12950899
[TBL] [Abstract][Full Text] [Related]
13. Quantitation of ergosterol content: novel method for determination of fluconazole susceptibility of Candida albicans.
Arthington-Skaggs BA; Jradi H; Desai T; Morrison CJ
J Clin Microbiol; 1999 Oct; 37(10):3332-7. PubMed ID: 10488201
[TBL] [Abstract][Full Text] [Related]
14. Comparative evaluation of alternative methods for broth dilution susceptibility testing of fluconazole against Candida albicans.
Pfaller MA; Grant C; Morthland V; Rhine-Chalberg J
J Clin Microbiol; 1994 Feb; 32(2):506-9. PubMed ID: 8150963
[TBL] [Abstract][Full Text] [Related]
15. Comparison of three methods for testing azole susceptibilities of Candida albicans strains isolated sequentially from oral cavities of AIDS patients.
Tortorano AM; Viviani MA; Barchiesi F; Arzeni D; Rigoni AL; Cogliati M; Compagnucci P; Scalise G
J Clin Microbiol; 1998 Jun; 36(6):1578-83. PubMed ID: 9620380
[TBL] [Abstract][Full Text] [Related]
16. Testing susceptibility of Candida species to fluconazole and itraconazole using the microdilution assay.
Seibold M; Werner E
Mycoses; 1995; 38(11-12):443-8. PubMed ID: 8720193
[TBL] [Abstract][Full Text] [Related]
17. Effects of incubation time and buffer concentration on in vitro activities of antifungal agents against Candida albicans.
Tornatore MA; Noskin GA; Hacek DM; Obias AA; Peterson LR
J Clin Microbiol; 1997 Jun; 35(6):1473-6. PubMed ID: 9163465
[TBL] [Abstract][Full Text] [Related]
18. Comparative evaluation of macrodilution and chromogenic agar screening for determining fluconazole susceptibility of Candida albicans.
Patterson TF; Kirkpatrick WR; Revankar SG; McAtee RK; Fothergill AW; McCarthy DI; Rinaldi MG
J Clin Microbiol; 1996 Dec; 34(12):3237-9. PubMed ID: 8940483
[TBL] [Abstract][Full Text] [Related]
19. [The value of the agar dilution method as a screening test for determining the sensitivity of Candida albicans to fluconazole].
Yücesoy M; Marol S
Mikrobiyol Bul; 2002; 36(3-4):317-22. PubMed ID: 12838666
[TBL] [Abstract][Full Text] [Related]
20. Influence of different susceptibility testing methods and media on determination of the relevant fluconazole minimum inhibitory concentrations for heavy trailing Candida isolates with low-high phenotype.
Alp S; Sancak B; Hascelik G; Arikan S
Mycoses; 2010 Nov; 53(6):475-80. PubMed ID: 19563491
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
